959 related articles for article (PubMed ID: 31835440)
21. Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.
He Y; Weinberg MS; Hirsch M; Johnson MC; Tisch R; Samulski RJ; Li C
Hum Gene Ther; 2013 May; 24(5):545-53. PubMed ID: 23534873
[TBL] [Abstract][Full Text] [Related]
22. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
[TBL] [Abstract][Full Text] [Related]
23. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
[TBL] [Abstract][Full Text] [Related]
24. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
Rutledge EA; Halbert CL; Russell DW
J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
[TBL] [Abstract][Full Text] [Related]
25. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
[TBL] [Abstract][Full Text] [Related]
26. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE
J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709
[TBL] [Abstract][Full Text] [Related]
27. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tissue tropism determinants of adeno-associated virus type 1.
Hauck B; Xiao W
J Virol; 2003 Feb; 77(4):2768-74. PubMed ID: 12552020
[TBL] [Abstract][Full Text] [Related]
29. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
30. AAV8 capsid variable regions at the two-fold symmetry axis contribute to high liver transduction by mediating nuclear entry and capsid uncoating.
Tenney RM; Bell CL; Wilson JM
Virology; 2014 Apr; 454-455():227-36. PubMed ID: 24725949
[TBL] [Abstract][Full Text] [Related]
31. The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.
Raupp C; Naumer M; Müller OJ; Gurda BL; Agbandje-McKenna M; Kleinschmidt JA
J Virol; 2012 Sep; 86(17):9396-408. PubMed ID: 22718833
[TBL] [Abstract][Full Text] [Related]
32. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
[TBL] [Abstract][Full Text] [Related]
33. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R
J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260
[TBL] [Abstract][Full Text] [Related]
34. Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins.
Jin X; Liu L; Nass S; O'Riordan C; Pastor E; Zhang XK
Hum Gene Ther Methods; 2017 Oct; 28(5):255-267. PubMed ID: 28627251
[TBL] [Abstract][Full Text] [Related]
35. Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.
Johnson JS; Li C; DiPrimio N; Weinberg MS; McCown TJ; Samulski RJ
J Virol; 2010 Sep; 84(17):8888-902. PubMed ID: 20573820
[TBL] [Abstract][Full Text] [Related]
36. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions.
Grieger JC; Johnson JS; Gurda-Whitaker B; Agbandje-McKenna M; Samulski RJ
J Virol; 2007 Aug; 81(15):7833-43. PubMed ID: 17507473
[TBL] [Abstract][Full Text] [Related]
37. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.
Halbert CL; Rutledge EA; Allen JM; Russell DW; Miller AD
J Virol; 2000 Feb; 74(3):1524-32. PubMed ID: 10627564
[TBL] [Abstract][Full Text] [Related]
38. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.
Khabou H; Desrosiers M; Winckler C; Fouquet S; Auregan G; Bemelmans AP; Sahel JA; Dalkara D
Biotechnol Bioeng; 2016 Dec; 113(12):2712-2724. PubMed ID: 27259396
[TBL] [Abstract][Full Text] [Related]
39. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes.
Mary B; Maurya S; Arumugam S; Kumar V; Jayandharan GR
FEBS J; 2019 Dec; 286(24):4964-4981. PubMed ID: 31330090
[TBL] [Abstract][Full Text] [Related]
40. K137R mutation on adeno-associated viral capsids had minimal effect on enhancing gene delivery in vivo.
Qiao C; Li C; Zhao C; Li J; Bian T; Grieger J; Li J; Samulski RJ; Xiao X
Hum Gene Ther Methods; 2014 Feb; 25(1):33-9. PubMed ID: 24116972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]